首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >The International Registry on Hand and Composite Tissue Transplantation.
【24h】

The International Registry on Hand and Composite Tissue Transplantation.

机译:国际手和复合组织移植登记处。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: The International Registry on Hand and Composite Tissue Transplantation was founded in May 2002, and the analysis of all cases with follow-up information up to July 2010 is presented here. METHODS: From September 1998 to July 2010, 49 hands (17 unilateral and 16 bilateral hand transplantations, including 1 case of bilateral arm transplantation) have been reported, for a total of 33 patients. They were 31 men and 2 women (median age 32 years). Time since hand loss ranged from 2 months to 34 years, and in 46% of cases, the level of amputation was at wrist. Immunosuppressive therapy included tacrolimus, mycophenolate mofetil, sirolimus, and steroids; polyclonal or monoclonal antibodies were used for induction. Topical immunosuppression was also used in several cases. Follow-up ranges from 1 month to 11 years. RESULTS: One patient died on day 65. Three patients transplanted in the Western countries have lost their graft, whereas until September 2009, seven hand grafts were removed for noncompliance to the immunosuppressive therapy in China. Eighty-five percent of recipients experienced at least one episode of acute rejection within the first year, and they were reversible when promptly treated. Side effects included opportunistic infections, metabolic complications, and malignancies. All patients developed protective sensibility, 90% of them developed tactile sensibility, and 82.3% also developed a discriminative sensibility. Motor recovery enabled patients to perform most daily activities. CONCLUSIONS: Hand transplantation is a complex procedure, and its success is based on patient's compliance and his or her careful evaluation before and after transplantation.
机译:背景:国际手和复合组织移植注册机构成立于2002年5月,此处介绍了截至2010年7月的所有病例的随访信息。方法:1998年9月至2010年7月,共报告33例患者的49只手(17例单侧和16例双侧手移植,包括1例双侧手臂移植)。他们是31名男性和2名女性(中位年龄32岁)。失去手的时间从2个月到34年不等,在46%的情况下,截肢的程度在腕部。免疫抑制疗法包括他克莫司,霉酚酸酯,西罗莫司和类固醇。多克隆或单克隆抗体用于诱导。局部免疫抑制也用于几种情况。随访范围为1个月至11年。结果:一名患者在第65天死亡。在西方国家中有3例患者的移植物丢失,而直到2009年9月,由于不符合中国的免疫抑制疗法,已切除了7例人工移植物。百分之八十五的接受者在第一年内经历了至少一次急性排斥反应,如果及时治疗,它们是可逆的。副作用包括机会感染,代谢并发症和恶性肿瘤。所有患者均产生保护性敏感性,其中90%产生触觉敏感性,而82.3%的患者也产生区分性敏感性。运动恢复使患者能够执行大多数日常活动。结论:手移植是一个复杂的过程,其成功取决于患者的依从性以及他或她在移植前后的仔细评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号